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Significance of this study
What is already known about this subject?
 ► Pregnancies of women with type 1 diabetes mellitus 
(T1DM) have increased risk of perinatal morbidity 
and mortality. Good prenatal and antenatal care can 
improve pregnancy outcomes.
What are the new findings?
 ► There is a high prevalence of unplanned pregnancy 
and poor uptake of prepregnancy care in mothers 
with juvenile- onset T1DM.
How might these results change the focus of 
research or clinical practice?
 ► Quality improvement initiatives and future research 
need to be conducted in order to improve uptake 
of prepregnancy care. Clinicians treating infants of 
mothers with juvenile- onset T1DM should have a 
low threshold for admission to the neonatal unit.
AbStrAct
Background Pregnancy in women with type 1 diabetes 
mellitus (T1DM) is associated with an increased risk 
of congenital malformations, obstetric complications 
and neonatal morbidity. This study aims to investigate 
maternal, perinatal and neonatal outcomes of pregnancies 
in women with onset of T1DM less than 18 years of age.
Methods This retrospective cohort study extracted data 
regarding prenatal, intrapartum and postnatal outcomes 
of pregnancies in women with onset of T1DM<18 years 
identified from the diabetes in pregnancy register at 
University Maternity Hospital Limerick, treated from July 1, 
2007 to July 1, 2017.
Results Seventeen women with onset of T1DM <18 years 
gave birth to 23 live infants during the period studied. 
73.9% of pregnancies were unplanned. Only 21.7% of 
pregnancies took preconceptual folic acid. 60.9% of 
infants required treatment for hypoglycemia.
Conclusion The high prevalence of unplanned pregnancy 
and poor uptake of prepregnancy care must be improved 
on in order to improve outcomes for this high- risk group.
InTRoduCTIon
Pregnancy in women with type 1 diabetes 
mellitus (T1DM) is associated with increased 
maternal and neonatal morbidity and 
mortality.1–6 In order to minimize risks to both 
mothers and infants, good interdisciplinary 
care is required between diabetologists, obste-
tricians, neonatologists, nursing and allied 
health professional specialists. Women with 
T1DM in pregnancy in Ireland are cared for 
according to ‘Adult Type 1 Diabetes Mellitus 
National Clinical Guideline No. 17’7 which 
contextualizes the NICE 2015 Diabetes in 
Pregnancy Guideline8 for the Irish context. 
Patients with T1DM in pregnancy should be 
cared for in a joint diabetes and antenatal 
clinic and should have contact every 1–2 
weeks for assessment of blood glucose control 
throughout pregnancy.7 8
The largest Irish study to date of women 
with T1DM was a retrospective cohort study 
of pregnancies delivered in the three tertiary 
level maternity units in Dublin in 2006.9 This 
study of 25 847 pregnancies found 80 (0.31%) 
women had either T1DM or cystic fibrosis- 
related diabetes (CFRD). The severity/
complexity of their T1DM/CFRD when 
graded according to White’s Classification10 
showed n=58 (72.5%) women were class B or 
C (<10 years of T1DM or 10–19 years T1DM 
with no retinopathy or nephropathy); 14 
women (17.5%) were class D (>20 years with 
no retinopathy or nephropathy), 6 women 
were class R (presence of diabetic retinop-
athy), 1 woman was class F (diabetic nephrop-
athy) and 1 woman had diabetes mellitus 
secondary to cystic fibrosis.
The largest prospective study to date on 
pregnancy outcomes in T1DM is a multi-
center study which took place across eight 
Danish centers from 1993 to 1999.4 This study 
of 990 women with 1218 pregnancies showed 
a relative risk (RR) of 4.1 (95% CI 2.9 to 5.6) 
for perinatal mortality, RR 4.7 (95% CI 3.2 to 
7.0) for stillbirth and RR 1.7 (95% CI 1.3 to 
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Table 1 Demographics and baseline characteristics
Number of women 17
Median age at diagnosis 11 years (IQR 10–12)
Primiparous pregnancies 9 (39.1%)
Number of pregnancies 23
Multiple births 0
Median gestation at delivery 37.6 weeks (IQR 36–38.6)
Median birth weight 3.67 kg (IQR 3.1–3.8)
Gender 14 male (60.9%)
IQR, interquartile range.
Table 2 Maternal non- diabetes- related medical conditions




Asthma (n=2) Diabetic retinopathy (n=5)
Depression (n=2) Recurrent urinary tract 
infections (n=2)
Hashimoto’s thyroiditis (n=1) Diabetic nephropathy 
(n=2)
Carcinoid tumor of the appendix 
(n=1)
Hypertension (n=2)
Hypercholesterolemia (n=1) Poor hypoglycemia 
awareness (n=2)
Gastroesophageal reflux (n=1) Diabetic neuropathy (n=1)
Bicuspid aortic valve (n=1) Cataracts (n=1)
Irritable bowel syndrome (n=1)   
Benign kidney cyst (n=1)   
History of elevated prolactin of 
undefined etiology (n=1)
  
Table 3 Classification of pregnancies according to White’s 
Classification of Diabetes in Pregnancy10
Pregnancies 
(n=23)
Class A1: Gestational diabetes; diet 
controlled
Class A2: Gestational diabetes; 
medication controlled
Class B: Onset at age 20 years or older 
or with duration of less than 10 years
Class C: Onset at age 10–19 years or 
duration of 10–19 years
11 (47.8%)
Class D: Onset before age 10 years or 
duration greater than 20 years
6 (26.1%)
Class E: Overt diabetes mellitus with 
calcified pelvic vessels
Class F: Diabetic nephropathy 1 (4.3%)
Class R: Proliferative retinopathy 2 (8.7%)
Class RF: Retinopathy and nephropathy 3 (13%)
Class H: Ischemic heart disease
Class T: Prior kidney transplant
2.2) for congenital malformation, as compared with the 
general population.4
The primary aim of our study was to define maternal, 
perinatal and neonatal outcomes of pregnancies in 
women with onset of T1DM <18 years age in Ireland, 
attending a university affiliated maternity and neonatal 
service. A secondary aim was to describe modifiable risk 
factors for adverse outcomes which might be used as a 
basis for quality improvement locally.
MeTHods
This retrospective cohort study was performed at Univer-
sity Maternity Hospital Limerick, which delivers approx-
imately 5000 pregnancies per year and has specialist 
diabetes in pregnancy services for the wider Midwest 
region (population approximately 380 000). Women with 
T1DM delivering between July 1, 2007 and July 1, 2017 
were identified from the diabetes in pregnancy register. 
Inclusion criteria included age less than 18 years at diag-
nosis of T1DM which was confirmed via chart review. 
Exclusion criteria included stillbirth (defined as loss of 
pregnancy >24 weeks gestation), miscarriage (defined as 
loss of pregnancy ≤23 weeks gestation), termination of 
pregnancy, loss to follow- up or transfer of care to another 
center prior to delivery. All relevant data protection laws 
were followed. The data were analyzed with descriptive 
statistics using SPSS V.25.
ResulTs
demographics
Demographics and baseline characteristics are described 
in table 1. One case was excluded due to fatal fetal abnor-
mality. Six cases were excluded due to miscarriage.
Antenatal characteristics
Seventeen of 23 pregnancies (73.9%) were unplanned 
and 4/23 (8.7%) were smoking at the time of booking. 
Two of 17 women (11.7%) had a past history of illicit drug 
use. There was no documented evidence of active drug 
use during pregnancy. At the time of conception folate 
was being taken in only 5 of 23 pregnancies (21.7%).
Maternal prepregnancy morbidity
Fifteen of 17 women (88.2%) had medical diagnoses 
other than T1DM, while 8/17 women (47.1%) had 
diabetes- related complications (table 2). When each 
pregnancy is considered according to White’s Classifi-
cation of Diabetes in Pregnancy10 (table 3), there were 
11/23 (47.8%) class C pregnancies, 6/23 (26.1%) class 
D pregnancies, 3/23 (13%) class RF pregnancies, 2/23 
(8.7%) class R pregnancies and 1/23 (4.3%) class F preg-
nancy. Of the five women who had subsequent births 
during the 10- year study period one woman progressed 
from stage B to stage C and one woman progressed from 
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box 1 Recorded indication for admission to the neonatal 
unit
Hypoglycemia (n=14)
Jaundice requiring phototherapy (n=10)









stage F to stage RF. When each of these 17 women are 
considered according to their most severe classification, 
8/17 women (47.1%) were class C, 4/17 (23.5%) class D, 
3/17 (17.6%) women class RF and 2/17 (11.8%) women 
class R.
HbA1C values prepregnancy
The prepregnancy HbA1c (Haemoglobin A1c) value 
was taken as the last recorded laboratory value prior 
to conception. Only 4/23 pregnancies (17.4%) had 
HbA1c<48 mmol/mol prior to conception. Two of 23 
pregnancies (8.7%) had HbA1c>86 mmol/mol prior to 
conception.
Antenatal obstetric screening and complications
Anomaly scans were performed in 21 of 23 pregnancies 
(91.3%). Twelve of 23 pregnancies (52.2%) had ante-
natal complications; 4/23 (17.4%) had polyhydramnios, 
4/23 (17.4%) had intrauterine growth restriction, 2/23 
(8.7%) had pre- eclampsia, 1/23 (4.3%) had a hypogly-
cemic seizure and 1/23 (4.3%) had pregnancy- induced 
hypertension.
delivery and complications
Nineteen of 23 pregnancies (82.6%) were delivered 
by lower segment cesarean section (LSCS). Of these, 
15/23 (65.2%) were born via elective LSCS and 4/23 
(17.4%) via emergency LSCS. One pregnancy (4.3%) 
was delivered via instrumental delivery, while the 
remaining 3/23 (13%) pregnancies were delivered 
via spontaneous vaginal delivery. Of the total 4/23 
neonates (17%) born via vaginal delivery, there were no 
cases of shoulder dystocia. Four of 23 neonates (17.4%) 
required free- flow O2 at birth and 2/23 neonates (8.7%) 
required bag- mask ventilation. No babies required 
intubation or chest compressions in the delivery suite. 
The median APGAR11 at 1 min was 9 (range 5–9) and 
at 5 min was 10 (range 4–10). Vitamin K was given to all 
neonates. There were no neonatal deaths during the 
study period.
Postnatal advice and feeding patterns
Twenty of 23 neonates (87%) were bottle- fed. Twenty of 
23 pregnancies (87%) had preconception advice and 
contraception discussed at discharge.
neonatal problems
Twenty- two of 23 neonates (95.7%) were admitted to 
the neonatal unit. Standard care during the period 
studied for neonates born to mothers with T1DM 
included; feeding within the first hour, 3 hourly feeds 
and glucose measurement prior to the second feed 
until measurements were >3 mmol/L for two consecu-
tive feeds. Specific diagnoses of admitted neonates are 
outlined in box 112 . Thirteen of 23 neonates (56.5%) 
were admitted for treatment of hypoglycemia. One 
other neonate (4.3%) was admitted for observation 
following treatment of hypoglycemia on the postnatal 
ward. Of the 14 neonates treated for hypoglycemia, 
10/14 (71.4%) required an intravenous dextrose bolus. 
The median point- of- care blood glucose on admission 
was 1.9 mmol/L (range 0.8–2.8). Of the 15 neonates 
treated with intravenous fluids, 1 required 15% 
dextrose in intravenous fluids to maintain euglycemia, 
all other neonates required only 10% dextrose. There 
was no documented use of oral glucose gel for manage-
ment of hypoglycemia. Of the 10 neonates treated for 
jaundice, 100% received phototherapy; 2/10 (20%) 
were direct Coombs test positive, and none received 
intravenous immunoglobulin or exchange transfusion. 
Two of 23 neonates (8.7%) were macrosomic (birth 
weight >4.5 kg), however 8/23 neonates (34.8%) were 
large for gestational age, >90th centile. One neonate 
did not have any documented indication for admission 
and was a ‘well baby admitted for monitoring’ who did 
not develop any medical complications.
dIsCussIon
In 1989, the St. Vincent declaration stated that the 
outcomes of diabetic pregnancies should approximate 
those of non- diabetic pregnancies within 5 years.12 Our 
study demonstrates that this target has not been met. 
Although a potentially modifiable factor, suboptimal 
glycemic control is not wholly responsible for adverse 
outcomes of infants born to mothers with T1DM.13 The 
Diabetes Control and Complications Trial has shown 
that it is possible to reduce morbidity owing to T1DM 
before, during and after pregnancy, but not to elimi-
nate it.6 7
Our study shows a substantial comorbidity burden in 
this vulnerable population. Prepregnancy care is proven 
to improve outcomes.14 15 Most women in this study 
did not attend for prepregnancy care, presumably as 
most pregnancies (73.9%) were unplanned. In contrast 
a 2017 cohort study by Wotherspoon et al reported a 
significantly lower rate of unplanned pregnancy at 
39% in a population of 747 women with T1DM.16 
Characteristics associated with unplanned pregnancy 
included in this study were younger age at conception 
(p<0.001), being a current smoker (p<0.001), lower 
social class (p<0.001) and higher HbA1c value prior 
 on M











are: first published as 10.1136/bm





4 BMJ Open Diab Res Care 2020;8:e001080. doi:10.1136/bmjdrc-2019-001080
Clinical Care/Education/Nutrition
to and throughout pregnancy. Infants of these women 
were also more likely to be small for gestational age 
(<5th centile, p=0.004), to be admitted to the neonatal 
care unit (p=0.001) and have a longer stay in hospital 
(p=0.01).16
In our study, 21.7% of women were taking supple-
mental folic acid at the time of booking. This is lower 
than the rate of 41.8% in the British National Preg-
nancy in Diabetes Audit2 (NPID). The current recom-
mendation by the National Institute for Health and 
Care Excellence (NICE) for folic acid supplementation 
is 5 mg/day until 12 weeks gestation.8
The 2015 NICE guidelines also advise women with 
diabetes who are planning to become pregnant to 
maintain HbA1c<48 mmol/mol as this is associated with 
a reduction in congenital anomalies to close to back-
ground population rates.8 Fewer than one in five preg-
nancies in our study population met this target. The 
2015 NICE guidelines also strongly advise women with 
diabetes whose HbA1c is above 86 mmol/mol not to get 
pregnant because of the associated risks. Of the case 
population on our study, 8.7% (n=2/23) met this defi-
nition. In contrast the NPID found that 14.9% of preg-
nancies of women with T1DM had HbA1c<48 mmol/L 
and that 12.5% had HBA1c>86 mmol/L.2
While women with T1DM are known to have a signifi-
cantly higher LSCS rate than the general population, 
the proportion in this study (82.6%) is higher than 
other similar studies, which reported rates varying from 
46% to 64.7%.4–6 13 17 The rate of premature delivery 
(30.4%) identified in this cohort is broadly similar to 
other studies in the literature which vary from 21% to 
43.3%.4–6 13 17 18 Fortunately there were no perinatal 
deaths in this study. The reported perinatal mortality 
rate for women with T1DM in the literature varies from 
1.8% to 4.3%.4–6 13 17 19 Of infants of mothers with T1DM 
in this study 95.7% were admitted to the neonatal unit, 
however not all infants admitted had documented 
pathology. The prevalence of large for gestational age 
in this study was 34.8%, lower than previous studies 
which reported rates varying from 45.1% to 59%.17 20–23 
The incidence of neonatal hypoglycemia noted by this 
study (60.9%) is in keeping with the incidence of hypo-
glycemia noted in the literature, 25.3% to 63%.23 24
The high prevalence of unplanned pregnancy with 
a poor uptake of structured prepregnancy care must 
be improved on in order to improve outcomes for this 
high- risk group. In order to address this, future quality 
improvement measures will need to be implemented to 
reinforce the issue further in pediatric clinics, at tran-
sition and on an ongoing basis into adult care. Future 
audits will be required to assess the impact of these 
measures.
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